The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice

Tuberculosis remains a major global health problem and effective vaccines are urgently needed. In this study, we used the combined DNA- and protein-based vaccines of immunodominant antigen Rv0577 to boost BCG and evaluated their immunogenicity in BALB/c mice. Our data suggest that the booster vaccin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta biochimica et biophysica Sinica 2016-04, Vol.48 (4), p.385-390
Hauptverfasser: Gu, Dongqing, Chen, Wei, Mi, Youjun, Gong, Xueli, Luo, Tao, Bao, Lang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 390
container_issue 4
container_start_page 385
container_title Acta biochimica et biophysica Sinica
container_volume 48
creator Gu, Dongqing
Chen, Wei
Mi, Youjun
Gong, Xueli
Luo, Tao
Bao, Lang
description Tuberculosis remains a major global health problem and effective vaccines are urgently needed. In this study, we used the combined DNA- and protein-based vaccines of immunodominant antigen Rv0577 to boost BCG and evaluated their immunogenicity in BALB/c mice. Our data suggest that the booster vaccine may substantially enhance the immunogenicity of BCG and strengthen both CD4+ T cell-mediated Th1 and CD8+ T cell-mediated cytolytic responses. Compared with the protein-based vaccine, the DNA-based vaccine can induce more durable Th1 immune response, characterized by high levels of antibody response, proliferation response, percentages of CD4+/CD8+ and cytokine secretion in antigen-stimulated splenocyte cultures. In conclusion, we for the first time, developed a protein- and plasmid DNA-based booster vaccine based on Rv0577. Our findings suggest that antigen Rv0577-based DNA vaccine is immunogenic and can efficiently boost BCG, which could be helpful in the design of an efficient vaccination strategy against TB.
doi_str_mv 10.1093/abbs/gmw010
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4886249</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1776088697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-a4cf76ad522617f6f08439f6fbcbbc88bdc305a39088ffb87607b8ce3b6b73243</originalsourceid><addsrcrecordid>eNpVkUtr3DAUhUVpaR7tKvuiZaE40cuSvAkk07wgbaFM10KSrzMqtjWR7An599EwSUhW98L5OOdeDkJHlBxT0vAT61w-uRseCCUf0D5Voq4UU-Rj2aViVUNFvYcOcv5PCJeSks9oj8mGMc7IPuqXK8C_Hn101k-QwjxgFzch4_PFFV6nMED1d0NqpfDP32dFinnCG-t9GO0U4ojD2M4eMra4nZN1PeDliuIwDPMIOEFexzFDofAQPHxBnzrbZ_j6PA_Rv8uL5eK6uv1zdbM4u608F2KqrPCdkratGZNUdbIjWvCmTOed81q71nNSW94QrbvOaSWJctoDd9IpzgQ_RKc73_XsBmg9jFOyvdm-Y9OjiTaY98oYVuYubozQWjLRFIPvzwYp3s-QJzOE7KHv7QhxzoaqklnYRhX0xw71KeacoHuNocRs-zHbfsyun0J_e3vZK_tSCH8C3QGODA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776088697</pqid></control><display><type>article</type><title>The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Gu, Dongqing ; Chen, Wei ; Mi, Youjun ; Gong, Xueli ; Luo, Tao ; Bao, Lang</creator><creatorcontrib>Gu, Dongqing ; Chen, Wei ; Mi, Youjun ; Gong, Xueli ; Luo, Tao ; Bao, Lang</creatorcontrib><description>Tuberculosis remains a major global health problem and effective vaccines are urgently needed. In this study, we used the combined DNA- and protein-based vaccines of immunodominant antigen Rv0577 to boost BCG and evaluated their immunogenicity in BALB/c mice. Our data suggest that the booster vaccine may substantially enhance the immunogenicity of BCG and strengthen both CD4+ T cell-mediated Th1 and CD8+ T cell-mediated cytolytic responses. Compared with the protein-based vaccine, the DNA-based vaccine can induce more durable Th1 immune response, characterized by high levels of antibody response, proliferation response, percentages of CD4+/CD8+ and cytokine secretion in antigen-stimulated splenocyte cultures. In conclusion, we for the first time, developed a protein- and plasmid DNA-based booster vaccine based on Rv0577. Our findings suggest that antigen Rv0577-based DNA vaccine is immunogenic and can efficiently boost BCG, which could be helpful in the design of an efficient vaccination strategy against TB.</description><identifier>ISSN: 1672-9145</identifier><identifier>EISSN: 1745-7270</identifier><identifier>DOI: 10.1093/abbs/gmw010</identifier><identifier>PMID: 26922320</identifier><language>eng</language><publisher>China: Oxford University Press</publisher><subject>Animals ; Antibodies, Bacterial - blood ; BCG Vaccine - administration &amp; dosage ; BCG Vaccine - immunology ; Female ; Mice ; Mice, Inbred BALB C ; Mycobacterium bovis - immunology ; Original ; Th1 Cells - classification ; Th1 Cells - immunology ; Vaccines, DNA - administration &amp; dosage ; Vaccines, DNA - immunology</subject><ispartof>Acta biochimica et biophysica Sinica, 2016-04, Vol.48 (4), p.385-390</ispartof><rights>The Author 2016. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.</rights><rights>The Author 2016. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-a4cf76ad522617f6f08439f6fbcbbc88bdc305a39088ffb87607b8ce3b6b73243</citedby><cites>FETCH-LOGICAL-c344t-a4cf76ad522617f6f08439f6fbcbbc88bdc305a39088ffb87607b8ce3b6b73243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886249/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886249/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26922320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gu, Dongqing</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Mi, Youjun</creatorcontrib><creatorcontrib>Gong, Xueli</creatorcontrib><creatorcontrib>Luo, Tao</creatorcontrib><creatorcontrib>Bao, Lang</creatorcontrib><title>The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice</title><title>Acta biochimica et biophysica Sinica</title><addtitle>Acta Biochim Biophys Sin (Shanghai)</addtitle><description>Tuberculosis remains a major global health problem and effective vaccines are urgently needed. In this study, we used the combined DNA- and protein-based vaccines of immunodominant antigen Rv0577 to boost BCG and evaluated their immunogenicity in BALB/c mice. Our data suggest that the booster vaccine may substantially enhance the immunogenicity of BCG and strengthen both CD4+ T cell-mediated Th1 and CD8+ T cell-mediated cytolytic responses. Compared with the protein-based vaccine, the DNA-based vaccine can induce more durable Th1 immune response, characterized by high levels of antibody response, proliferation response, percentages of CD4+/CD8+ and cytokine secretion in antigen-stimulated splenocyte cultures. In conclusion, we for the first time, developed a protein- and plasmid DNA-based booster vaccine based on Rv0577. Our findings suggest that antigen Rv0577-based DNA vaccine is immunogenic and can efficiently boost BCG, which could be helpful in the design of an efficient vaccination strategy against TB.</description><subject>Animals</subject><subject>Antibodies, Bacterial - blood</subject><subject>BCG Vaccine - administration &amp; dosage</subject><subject>BCG Vaccine - immunology</subject><subject>Female</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mycobacterium bovis - immunology</subject><subject>Original</subject><subject>Th1 Cells - classification</subject><subject>Th1 Cells - immunology</subject><subject>Vaccines, DNA - administration &amp; dosage</subject><subject>Vaccines, DNA - immunology</subject><issn>1672-9145</issn><issn>1745-7270</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkUtr3DAUhUVpaR7tKvuiZaE40cuSvAkk07wgbaFM10KSrzMqtjWR7An599EwSUhW98L5OOdeDkJHlBxT0vAT61w-uRseCCUf0D5Voq4UU-Rj2aViVUNFvYcOcv5PCJeSks9oj8mGMc7IPuqXK8C_Hn101k-QwjxgFzch4_PFFV6nMED1d0NqpfDP32dFinnCG-t9GO0U4ojD2M4eMra4nZN1PeDliuIwDPMIOEFexzFDofAQPHxBnzrbZ_j6PA_Rv8uL5eK6uv1zdbM4u608F2KqrPCdkratGZNUdbIjWvCmTOed81q71nNSW94QrbvOaSWJctoDd9IpzgQ_RKc73_XsBmg9jFOyvdm-Y9OjiTaY98oYVuYubozQWjLRFIPvzwYp3s-QJzOE7KHv7QhxzoaqklnYRhX0xw71KeacoHuNocRs-zHbfsyun0J_e3vZK_tSCH8C3QGODA</recordid><startdate>20160401</startdate><enddate>20160401</enddate><creator>Gu, Dongqing</creator><creator>Chen, Wei</creator><creator>Mi, Youjun</creator><creator>Gong, Xueli</creator><creator>Luo, Tao</creator><creator>Bao, Lang</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160401</creationdate><title>The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice</title><author>Gu, Dongqing ; Chen, Wei ; Mi, Youjun ; Gong, Xueli ; Luo, Tao ; Bao, Lang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-a4cf76ad522617f6f08439f6fbcbbc88bdc305a39088ffb87607b8ce3b6b73243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antibodies, Bacterial - blood</topic><topic>BCG Vaccine - administration &amp; dosage</topic><topic>BCG Vaccine - immunology</topic><topic>Female</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mycobacterium bovis - immunology</topic><topic>Original</topic><topic>Th1 Cells - classification</topic><topic>Th1 Cells - immunology</topic><topic>Vaccines, DNA - administration &amp; dosage</topic><topic>Vaccines, DNA - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gu, Dongqing</creatorcontrib><creatorcontrib>Chen, Wei</creatorcontrib><creatorcontrib>Mi, Youjun</creatorcontrib><creatorcontrib>Gong, Xueli</creatorcontrib><creatorcontrib>Luo, Tao</creatorcontrib><creatorcontrib>Bao, Lang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta biochimica et biophysica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gu, Dongqing</au><au>Chen, Wei</au><au>Mi, Youjun</au><au>Gong, Xueli</au><au>Luo, Tao</au><au>Bao, Lang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice</atitle><jtitle>Acta biochimica et biophysica Sinica</jtitle><addtitle>Acta Biochim Biophys Sin (Shanghai)</addtitle><date>2016-04-01</date><risdate>2016</risdate><volume>48</volume><issue>4</issue><spage>385</spage><epage>390</epage><pages>385-390</pages><issn>1672-9145</issn><eissn>1745-7270</eissn><abstract>Tuberculosis remains a major global health problem and effective vaccines are urgently needed. In this study, we used the combined DNA- and protein-based vaccines of immunodominant antigen Rv0577 to boost BCG and evaluated their immunogenicity in BALB/c mice. Our data suggest that the booster vaccine may substantially enhance the immunogenicity of BCG and strengthen both CD4+ T cell-mediated Th1 and CD8+ T cell-mediated cytolytic responses. Compared with the protein-based vaccine, the DNA-based vaccine can induce more durable Th1 immune response, characterized by high levels of antibody response, proliferation response, percentages of CD4+/CD8+ and cytokine secretion in antigen-stimulated splenocyte cultures. In conclusion, we for the first time, developed a protein- and plasmid DNA-based booster vaccine based on Rv0577. Our findings suggest that antigen Rv0577-based DNA vaccine is immunogenic and can efficiently boost BCG, which could be helpful in the design of an efficient vaccination strategy against TB.</abstract><cop>China</cop><pub>Oxford University Press</pub><pmid>26922320</pmid><doi>10.1093/abbs/gmw010</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1672-9145
ispartof Acta biochimica et biophysica Sinica, 2016-04, Vol.48 (4), p.385-390
issn 1672-9145
1745-7270
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4886249
source MEDLINE; PubMed Central; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Animals
Antibodies, Bacterial - blood
BCG Vaccine - administration & dosage
BCG Vaccine - immunology
Female
Mice
Mice, Inbred BALB C
Mycobacterium bovis - immunology
Original
Th1 Cells - classification
Th1 Cells - immunology
Vaccines, DNA - administration & dosage
Vaccines, DNA - immunology
title The Mycobacterium bovis BCG prime-Rv0577 DNA boost vaccination induces a durable Th1 immune response in mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T19%3A08%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Mycobacterium%20bovis%20BCG%20prime-Rv0577%20DNA%20boost%20vaccination%20induces%20a%20durable%20Th1%20immune%20response%20in%20mice&rft.jtitle=Acta%20biochimica%20et%20biophysica%20Sinica&rft.au=Gu,%20Dongqing&rft.date=2016-04-01&rft.volume=48&rft.issue=4&rft.spage=385&rft.epage=390&rft.pages=385-390&rft.issn=1672-9145&rft.eissn=1745-7270&rft_id=info:doi/10.1093/abbs/gmw010&rft_dat=%3Cproquest_pubme%3E1776088697%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776088697&rft_id=info:pmid/26922320&rfr_iscdi=true